Perhexiline maleate is a small molecule active pharmaceutical ingredient that was first approved in 1974 for cardiovascular applications. It has undergone Phase IV clinical trials and has been withdrawn in at least one region.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 6724-53-4
Lanatoside C
cardiovascular active pharmaceutical ingredient
D-phenylalanine
Antidepressant pharmaceutical ingredient
Drospirenone 6-ene
progestin and antiandrogen medication
Drospirenone
Active pharmaceutical ingredient
Warfarin sodium
active pharmaceutical ingredient
(Z)-but-2-enedioic acid;2-(2,2-dicyclohexylethyl)piperidine
JDZOTSLZMQDFLG-BTJKTKAUSA-N
C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3.C(=C\C(=O)O)\C(=O)O